You are here

AusPAR: Siponimod

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

2 January 2020
AusPAR Details
AusPAR
Active Ingredient
Siponimod
Product Name
Mayzent
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Submission Number
PM-2018-04434-1-1
Submission Type
New chemical entity
Decision
Approved
AusPAR Date
11 December 2019
Publication Date

2 January 2020